)
Monogram Technologies (MGRM) investor relations material
Monogram Technologies Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Shareholders are notified of a special meeting scheduled for September 30, 2025, to vote on key proposals related to a proposed acquisition by Zimmer Biomet Holdings, Inc.
Shareholders are encouraged to transfer shares to a brokerage firm if desired, to streamline payment or enable trading prior to the merger.
Instructions for voting and transferring shares are provided, with emphasis on the importance of each vote.
Voting matters and shareholder proposals
Two proposals are up for vote at the special meeting, including approval of the merger.
The Board of Directors unanimously recommends voting FOR the merger and related proposals.
Not voting will have the same effect as voting against the merger.
Board of directors and corporate governance
The Board of Directors is actively communicating with shareholders and providing clear recommendations on voting.
- AI-driven orthopedic robotics firm files to offer up to $100M in flexible securities for growth.MGRM
Registration Filing - Stockholders to vote on merger offering $4.04 cash plus CVR per share; board recommends approval.MGRM
Proxy Filing - Zimmer Biomet to acquire Monogram for $4.04/share plus CVR; milestone payouts up to $12.37/share.MGRM
Proxy Filing - Annual meeting to vote on directors, auditor, stock plan amendment, and executive pay.MGRM
Proxy Filing - Stockholders to vote on merger with Zimmer Biomet, receiving $4.04 cash plus CVR per share.MGRM
Proxy Filing - Merger vote set: $4.04/share cash plus CVR; board and major holders back Zimmer Biomet deal.MGRM
Proxy Filing - $16.6M cash, $12.1M net loss YTD, FDA progress, and India trial set stage for 2025–2026 launch.MGRM
Q3 2024 - Autonomous robotic cutting technology targets a major shift in orthopedic surgery standards.MGRM
17th Annual LD Micro Main Event Conference - FDA and Indian clearances drive clinical trials and commercialization, with live surgeries imminent.MGRM
Q1 2025 - Strong cash, regulatory progress, and technical milestones drive robotic knee launch outlook.MGRM
Q4 2024
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)